Skip to content

Trial of a Distal Targeting System for Cephalomedullary Nails as Part of Surgical Repair of Hip and Femoral Shaft Fractures

Trial of a Distal Targeting System for Cephalomedullary Nails as Part of Surgical Repair of Hip and Femoral Shaft Fractures

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03943329
Enrollment
60
Registered
2019-05-09
Start date
2019-12-17
Completion date
2021-03-07
Last updated
2022-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral Shaft Fractures, Hip Fractures

Brief summary

This study will be a prospective, case - control trial looking at the use of a previously FDA approved device made by Stryker, a distal targeting system that eases the distal targeting of screws in cephalomedullary nails in hip and femoral shaft fractures. Patients who consent to participate in the study will either be in the control or device arm of the study depending on their surgeon.

Detailed description

Surgeries conducted by Dr. Konda or Dr. Leucht will be done using the device technique, surgeries completed by Dr. Egol or Dr. Tejwani will be done without the device, free hand technique. Each arm of the study will contain 29 patients. Patients who consent to participation will be enrolled in the study and placed in the correct arm based on who their surgeon is. Demographic and injury data will be collected. Intra-operatively, control patients will receive the SOC procedure. Device arm patients will have the distal targeting device used in their procedure, but the implant, will not be different than SOC.

Interventions

PROCEDUREDistal targeting device technique of distal screw placement

The second group will be the interventional group which will use the distal targeting device technique of distal screw placement and will be treated by Dr. Konda and Dr. Leucht. All relevant data to the study will be collected intra-operatively.

PROCEDUREStandard of Care

Will receive the standard of care free-hand technique of distal screw placement, as treated by Dr. Egol or Dr. Tejwani.

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The patient must be greater than or equal to 18 years of age. * The patient must have sustained a hip or femur fracture that is indicated for cephalomedullary nailing as the primary and definitive treatment measure. * The patient must be medically cleared for operative fixation of their fracture.

Exclusion criteria

* The patient does not meet all of the inclusion criteria.

Design outcomes

Primary

MeasureTime frame
Change in mean intra-operative radiation exposure to patients during their cephalomedullary nailing procedure.Baseline, 1 Day

Secondary

MeasureTime frame
Change in mean length of time to distal screw placementBaseline, 1 Day
Change in total operative timeBaseline, 1 Day
Change in total operative cost ($)Baseline, 1 Day

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026